Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 29, 2004BMJOpen Access

Antiretroviral therapy in Africa

View Full Paper
Ask AI
Bookmark
Share

Authors

WSWarren StevensCurry College

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Warren Stevens (2004) studied this question.

synapsesocial.com/papers/6aa03efb0e33995b3e3a787ahttps://doi.org/10.1136/bmj.328.7434.280
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Improving adherence to malaria treatment for children: the use of pre‐packed chloroquine tablets <i>vs</i>. chloroquine syrup2001 · 114 citations
  2. 2Extent of Cross-Resistance between Agents Used To Treat Human Immunodeficiency Virus Type 1 Infection in Clinically Derived Isolates2002 · 36 citations
  3. 3HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged Therapy1989 · 1,565 citations
  4. 4High levels of adherence do not prevent accumulation of HIV drug resistance mutations2003 · 256 citations